Maven Securities LTD Moderna, Inc. Transaction History

Maven Securities LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $556,189 - $730,413	5,769 New	5,769 $595,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $1.09 Million - $1.8 Million	9,247 Added 251.07%	12,930 $15.3 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $268,696 - $405,097	-2,294 Reduced 38.38%	3,683 $526,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $414,915 - $771,199	3,281 Added 121.7%	5,977 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $337,600 - $550,922	1,495 Added 124.48%	2,696 $685,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $732,048 - $1.6 Million	-3,299 Reduced 73.31%	1,201 $465,000
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $584,595 - $1.06 Million	4,500 New	4,500 $1.06 Million
Q4 2019 Feb 14, 2020	SELL	$13.93 - $21.28 $146,265 - $223,440	-10,500 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $128,730 - $189,735	10,500 New	10,500 $165,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.